jact03i4p282

Embed Size (px)

Citation preview

  • 8/8/2019 jact03i4p282

    1/4

    Anasarca in a Non-Cirrhotic Portal Fibrosis Patient

    after Spleno-Renal Shunt Procedure

    Anupam Prakash*, Samir Kubba*, NP Singh**, SK Agarwal***

    * Senior Resident, ** Professor, *** Director-Professor and Head,Department of Medicine, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi-110 002, India.

    P O S T G R A D U A T E C L I N I C

    An 18-year old girl presented with history of two episodes

    of haematemesis at the age of 6 years and 15 years. In

    between the two episodes, she complained of progressive

    abdominal distension, but was not certain whether it was

    restricted to left upper abdomen or was diffuse. She was

    diagnosed as a case of non-cirrhotic portal fibrosis (on

    liver biopsy), and doppler examination of abdomenshowed evidence of portal hypertension. She underwent

    spleno-renal shunt surgery. Four months after surgery, she

    presented with progressively increasing abdominal

    distension and swelling of feet and face over the last two

    months. On specific probing, the patient did reveal a

    history of reduced urine output for the last 2 days.

    However, there was no history of fever, haematuria, pyuria,

    dysuria, nocturia, cough, expectoration, chest pain, loose

    motions, vomiting, haematemesis, or malena. Clinical

    examination revealed a conscious, oriented patient, BP

    160/90 mm Hg, no icterus; but pallor, gross ascites, pedal

    and facial swelling were present. Systemic examination

    revealed decreased air entry at the right lung base with

    stony dull percussion note suggestive of right pleural

    effusion; however, the liver span was maintained.

    Investigations revealed : haemoglobin 8.9 g/dl, TLC 10,000/

    mm3, P75 L25, platelets 372,000/mm3, ESR 40 mm at the end

    of first hour, normocytic normochromic peripheral blood

    picture, blood urea 180 mg/dl, serum creatinine 6.4 mg/

    dl, serum sodium 140 meq/l, serum potassium 3.8 meq/l,

    random blood sugar 68 mg/dl, total serum bilirubin 0.8

    mg/dl, serum alanine transferase 26 units/l, serum alkaline

    phosphatase 13 KA units, total serum proteins 6 g/l, serum

    albumin 3.2 g/l. Chest radiograph revealed right pleural

    effusion. ECG was normal. Ultrasound doppler

    examination of the abdomen revealed normal liver span

    with slightly coarsened liver echotexture with multiple

    channels seen at the porta replacing middle portal vein,

    suggestive of portal cavernoma formation with gross

    ascites. Both the kidneys were reduced in size right

    kidney measuring 7 x 3 cm with cortical thickness of 5

    mm and left kidney measuring 8 x 4 cm with cortical

    thickness of 7 mm; both showed increased cortical

    echogenicity with partial loss of corticomedullary

    differentiation. The intrarenal arterial and venous flow

    patterns were preserved; bilateral renal veins were patent;and a tributary was seen opening into mid-portion of left

    renal vein.

    Urine output was 300 ml/24 hours and examination of

    urine revealed: 2+ albuminuria, 4-8 RBCs/HPF, fine and

    coarse granular casts. Prothrombin time was 18 seconds

    as against a control of 14 seconds. The patient was

    negative for hepatitis B surface and hepatitis B envelope

    antigens, and for antibodies against hepatitis C virus,

    hepatitis B core antigen, and HIV 1 and 2. HCV RNA was

    not done due to financial constraints. Ascitic tap and right

    pleural tap were transudative; serum to ascitic albumin

    gradient (SAAG) was 1.6. Blood, urine, and ascitic fluid

    cultures were sterile.

    Repeated abdominal paracentesis against albumin

    infusions were done since the patient appeared in obvious

    distress. Kidney biopsy was withheld in view of slight

    derangement of prothrombin time and uraemia. It was

    planned to be performed after a few dialysis sessions

    which would improve uraemia, and after vitamin K

    injections which would improve prothrombin time.

    Central venous pressure monitoring was done and the

    pressure varied from 8-10 cm of water, indicating there

    was no obvious intravascular volume contraction.

    However, renal functions continued to worsen and the

    ascites was refractory. Blood urea increased to 272 mg/dl

    and serum creatinine to 10 mg/dl over 2 weeks, with a

    urine output of 150 ml/24 hours. The patient was initiated

    on intensive haemodialysis and blood transfusion support.

    She continued to be oliguric, and expired due to uraemic

    JIACM 2003; 4(4): 282-5

  • 8/8/2019 jact03i4p282

    2/4

    complications (refractory fluid overload, severe metabolic

    acidosis, hyperkalaemia). Unfortunately, the relatives

    refused a post-mortem kidney biopsy.

    Question 1 : What were the problems in thispatient?

    Answer 1 : This is a young female who was diagnosed as

    a case of non-cirrhotic portal fibrosis (NCPF) and was

    negative for viral markers of hepatitis A, B, C, and E. In view

    of recurrent haematemesis and recalcitrant ascites, porto-

    systemic shunting procedure was performed, namely, the

    spleno-renal shunt. The patient, however, developed

    anasarca 4 months after surgery, associated with oliguria

    and serial derangement of renal parameters including

    reduction of renal size.

    Question 2 : What are the common causes of

    anasarca?

    Answer 2 : The common causes of anasarca are :

    1. Anaemia and hypoproteinaemia

    2. Congestive cardiac failure

    3. Chronic liver disease

    4. Acute or chronic renal insufficiency, nephrotic

    syndrome

    5. Protein-losing enteropathies/malabsorptionsyndrome

    6. Wet Beri-beri

    7. Epidemic dropsy (Argemone mexicanaingestion)

    8. Myxoedema, may also simulate anasarca

    9. Angioneurotic oedema at times may also simulate

    anasarca.

    Question 3 : What are the clinical conditions

    in which simultaneous renal and hepatic

    involvement may be found?Answer 3 : Table I lists the various conditions in which

    both liver and kidneys are affected, but the liver disease

    does not play an aetiological role in the pathogenesis of

    renal failure. These conditions constitute the so-called

    pseudo-hepatorenal syndrome. The functional renal

    failure encountered in patients with severe liver disease

    is called hepatorenal syndrome (HRS) and liver disease is

    considered to be at the centre-point of its aetiology.

    Table I : Causes of pseudo-hepatorenal syndrome.

    1. Primary hepatic disease with secondary renal

    involvement :

    Obstructive jaundice Renal tubular acidosis,

    acute tubular necrosis

    Alcoholic liver disease IgA nephropathy, distal

    tubular acidosis

    HBV and HCV liver disease Glomerulonephritis,

    cryoglobulinaemia

    Autoimmune liver disease Distal tubular

    acidosis

    Cirrhosis of varied aetiology Impaired sodium

    and potassium excretion, pre-renal azotaemia,

    renal tubular acidosis, glomerulonephritis

    2. Primary renal diseases with secondary hepatic

    involvement :

    Hypernephroma Acute renal failure

    3. Disorders with simultaneous liver and kidney

    involvement :

    Congenital Polycystic disease, sickle cell

    anaemia

    Toxic agents Drugs, viz., tetracycline, halothane,

    acetaminophen, sulphonamides, rifampicin,

    allopurinol, and carbon tetrachloride poisoning

    in industrial workers

    Infections Miliary tuberculosis, hepatitis B,

    septicaemia, yellow fever, leptospirosis

    Connective tissue disorders

    Circulatory alterations Shock, heart failure

    Unknown aetiology Amyloidosis, sarcoidosis,

    Reyes syndrome.

    Question 4 : How would you diagnose

    hepatorenal syndrome and what are the

    points in favour of, or against it in this case?

    Answer 4 : Hepatorenal syndrome (HRS) is the final stage

    of complex haemodynamic derangements associated

    with portal hypertension, namely, peripheral arterial

    vasodilatation and reduced effective arterial blood

    volume which ultimately leads to intense renal

    vasoconstriction. It is characterised by worsening

    azotaemia with avid sodium retention and oliguria due

    to marked reduction in renal perfusion and glomerular

    filtration rate in the absence of any characteristic or

    significant histological abnormalities of kidneys. It is a

    common complication of patients with chronic liver

    Journal, Indian Academy of Clinical Medicine Vol. 4, No. 4 October-December 2003 283

  • 8/8/2019 jact03i4p282

    3/4

    284 Journal, Indian Academy of Clinical Medicine Vol. 4, No. 4 October-December 2003

    disease and ascites. HRS may need to be differentiated

    from pre-renal azotaemia and acute tubular necrosis;

    which is outlined in Table II1,2. At times, HRS may be

    precipitated by severe gastrointestinal bleeding, sepsis,

    or overly vigorous attempts at diuresis or paracentesis.HRS may mimic pre-renal azotaemia very closely, which

    at times may be superimposed on HRS. However, pre-renal

    azotaemia is often accompanied by increased

    haematocrit, orthostatic rise in pulse rate with a fall in

    blood pressure. If plasma expansion leads to an increase

    in central venous pressure upto 10 cm of water without

    any improvement in urine output, pre-renal azotaemia is

    unlikely.

    although a kidney biopsy could not be performed in this

    case, since the patient presented to us with markedly

    deranged renal functions. In a pioneering study3 on NCPF

    patients undergoing spleno-renal shunt surgery, it was

    reported that the incidence of proteinuria increased from7% during the pre-operative period to 32% during the

    post-operative follow-up. Clinical presentation as

    nephrotic syndrome was seen in 28% over a 5-year follow-

    up. Microhaematuria worsened from 6% at one month

    post-operatively to 25% after 4 years. In the

    glomerulonephritis patients, serum creatinine worsened

    from a pre-operative value of 1 mg% to 3.3 mg% at 5 years.

    Similar findings were not seen in patients of extrahepatic

    Table II : Differentiation of HRS from pre-renal azotaemia and acute tubular necrosis (ATN).

    Differentiating characteristic HRS Pre-renal azotaemia ATNHistory of precipitating event May or may Invariably present; Present with fluid loss, shock,

    not be present loss of fluids evident sepsis, or nephrotoxic drugs

    Urine output Oliguria Oliguria Oliguria, anuria

    Urinary sediment Absent Hyaline casts Granular casts, cellular debris

    Urinary sodium (meq/l) < 5 < 10 > 20

    Urine to plasma osmolality ratio > 1.5 > 1.5 1

    Urine to plasma creatinine ratio > 40 > 40 < 20

    Response to plasma expansion Absent Good Absent

    This patient was subjected to abdominal paracentesis due

    to recalcitrant ascites, although they were done against

    albumin infusions. She was also on diuretics although she

    continued to have oliguria. No evidence of sepsis was

    evident, although inadvertent transient bacteraemia may

    have occurred since patient had peripheral intravenous

    access, central venous line, haemodialysis access, and

    abdominal paracentesis was also repeatedly performed,

    though with aseptic precautions. All these factors are

    known to precipitate HRS at times. Also, her central venous

    pressure was normal. The presence of a mild active urinarysediment and shrunken kidneys are strong points against

    the diagnosis of HRS.

    Question 5 What is the likely precipitating

    factor in this case?

    Answer 5 : Spleno-renal shunt operation is the probable

    precipitating factor for renal deterioration in this case. The

    active urinary sediment suggests glomerulonephritis,

    portal obstruction who underwent similar surgery.

    The exact pathogenesis of an increased occurrence of

    glomerulonephritis in NCPF patients following spleno-

    renal shunt surgery is unclear. It is known that the hepatic

    reticulo-endothelial system (RES) function in NCPF is poor,

    while it is intact in extrahepatic portal obstruction.

    Although the shunt is performed to reduce portal

    hypertension and thus prevent gastrointestinal

    haemorrhage, it enhances direct porto-systemic

    circulation leading to bypass of hepatic RES. This

    eliminates the first pass mechanism which is important

    for clearance of immune complexes emanating from the

    gastrointestinal tract, thereby leading to excessive delivery

    to the systemic circulation and resulting in immune-

    complex glomerulonephritis. A similar mechanism is

    believed to exist in cirrhosis also, where

    mesangioproliferative glomerulonephritis has been

    reported to occur after a spleno-renal shunt procedure4.

    However, similar procedure does not lead to renal

  • 8/8/2019 jact03i4p282

    4/4

    Journal, Indian Academy of Clinical Medicine Vol. 4, No. 4 October-December 2003 285

    involvement in extrahepatic portal obstruction where the

    hepatic RES is normal-functioning3. Therefore, it is agreed

    that spleno-renal shunting procedure alone is not the

    predisposing factor but it can be in the presence of poor

    hepatic clearance as in NCPF and cirrhotics.

    References

    1. Brady HR, Brenner BM. Acute renal failure. In: Braunwald E,

    Fauci AS, Kasper DL et al(eds.) Harrisons principles of Internal

    Medicine. New York:McGraw Hill, 15th edn, 2001; pp 1541-51.

    2. Chung RT, Podolsky DK. Cirrhosis and its complications. In:Braunwald E, Fauci AS, Kasper DL et al (eds.) Harrisons

    principles of Internal Medicine. New York:McGraw Hill, 15th

    edn, 2001; pp 1754-66.

    3. Dash SC, Bhuyan UN, Dinda AKet al. Increased incidence of

    glomerulonephritis following spleno-renal shunt surgery

    in non-cirrhotic portal fibrosis. Kidney Int1997; 52: 482-5.

    4. Rana SS, Das K, Mukhopadhyay S et al. Mesangial

    proliferative glomerulonephritis triggered by spleno-renal

    shunt in a cirrhotic patient. J Assoc Physicians India2002:

    50; 266-8.